Squarepoint’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Sell |
40,643
-35,206
| -46% | -$226K | ﹤0.01% | 2229 |
|
|
2025
Q1 | $269K | Buy |
75,849
+565
| +0.8% | +$2K | ﹤0.01% | 2238 |
|
|
2024
Q4 | $285K | Buy |
75,284
+27,279
| +57% | +$103K | ﹤0.01% | 2219 |
|
|
2024
Q3 | $156K | Sell |
48,005
-224,571
| -82% | -$728K | ﹤0.01% | 2248 |
|
|
2024
Q2 | $518K | Buy |
272,576
+113,267
| +71% | +$215K | ﹤0.01% | 1705 |
|
|
2024
Q1 | $452K | Buy |
159,309
+125,859
| +376% | +$357K | ﹤0.01% | 1724 |
|
|
2023
Q4 | $492K | Sell |
33,450
-6,550
| -16% | -$96.4K | ﹤0.01% | 1700 |
|
|
2023
Q3 | $732K | Sell |
40,000
-5,810
| -13% | -$106K | ﹤0.01% | 1448 |
|
|
2023
Q2 | $988K | Sell |
45,810
-45,916
| -50% | -$990K | ﹤0.01% | 1261 |
|
|
2023
Q1 | $2.69M | Buy |
91,726
+51,726
| +129% | +$1.52M | 0.01% | 730 |
|
|
2022
Q4 | $1.48M | Sell |
40,000
-1,792
| -4% | -$66.2K | 0.01% | 916 |
|
|
2022
Q3 | $1.18M | Buy |
+41,792
| New | +$1.18M | 0.01% | 998 |
|
|
2022
Q2 | – | Sell |
-15,000
| Closed | -$193K | – | 2099 |
|
|
2022
Q1 | $193K | Buy |
+15,000
| New | +$193K | ﹤0.01% | 1916 |
|